Medifast
MED
$25.74
Share price
-1.38%
Change (1 day)
-67.53%
Change (1 year)
Categories
P/S ratio for Medifast (MED)
P/S ratio as of June 2024 (TTM): 0.3180
According to Medifast's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.317952. At the end of 2023 the company had a P/S ratio of 0.6830.
P/S ratio history for Medifast from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.6830 | -13.38% |
| 2022 | 0.7885 | -50.54% |
| 2021 | 1.59 | -35.51% |
| 2020 | 2.47 | 36.85% |
| 2019 | 1.81 | -39.01% |
| 2018 | 2.96 | 7.2% |
| 2017 | 2.76 | 53.76% |
| 2016 | 1.80 | 36.75% |
| 2015 | 1.31 | -13.46% |
| 2014 | 1.52 | 58.1% |
| 2013 | 0.9603 | -5.72% |
| 2012 | 1.02 | 43.28% |
| 2011 | 0.7109 | -58.92% |
| 2010 | 1.73 | -36.52% |
| 2009 | 2.73 | 263.31% |
| 2008 | 0.7503 | -5.46% |
| 2007 | 0.7936 | -65.05% |
| 2006 | 2.27 | 38.32% |
| 2005 | 1.64 | 15.9% |
| 2004 | 1.42 | -75.68% |
| 2003 | 5.82 | 87.58% |
| 2002 | 3.10 | 979.66% |
| 2001 | 0.2876 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.23 | 286.56% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | 49.5 | 15,481.25% | 🇺🇸 USA |
 Bellerophon Therapeutics
BLPH | 0.1250 | -60.70% | 🇺🇸 USA |